Skip to content

Clinically and Radiologically comparing the efficiency of two different blood derivatives of patient, when used along with Implants that are placed on the same day of extraction and measuring stability of Implant and Bone loss around the Implant.

A COMPARATIVE EVALUATION OF IMPLANT STABILITY AND BONELOSS IN IMMEDIATELY PLACED IMPLANT IN FRESH EXTRACTION SOCKET WITH PLATELET RICH FIBRIN AND WITH ADVANCED-PLATELET RICH FIBRIN-A CLINICAL AND RADIOGRAPHIC STUDY - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064426
Enrollment
20
Registered
2024-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: Endosseous Implant with Platelet rich fibrin: Using 2700 RPM for 12 minutes in a centrifugal machine and using the Platelet rich fibrin achieved from it. Control Intervention1: Endosseo

Sponsors

Dr Mukesh kistamolla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Generalised good periodontal health. 2.Presence of tooth/ root stump indicated for extraction in posterior region of maxilla and mandible without any acute infections. 3.Favourable root anatomy.

Exclusion criteria

Exclusion criteria: 1.Inadequate oral hygiene. 2.Dilacerated and Ankylosed tooth. 3.Acute Peri-apical and periodontal infection in teeth indicated for extraction. 4.Chronic tobacco users. 5.Severe bruxism or clenching habits. 6.Presence of conditions requiring chronic routine prophylactic use of antibiotics or prolonged use of steroids. E.g.; history of rheumatic heart disease, bacterial endocarditis, cardiac vascular anomalies, prosthetic joint replacements etc. 7.History of renal failure, bleeding disorders, metabolic bone disorder, uncontrolled endocrine disorders, HIV infection, alcohol or drug abuse, etc 8.History of leucocyte dysfunction and deficiencies and history of neoplastic disease requiring the use of radiation or chemotherapy

Design outcomes

Primary

MeasureTime frame
To achieve implant stability quotient above 60Timepoint: at baseline, 3 months, 6 months

Secondary

MeasureTime frame
To achieve implant stability quotient around 90 & to achieve minimal or no bone loss.Timepoint: at baseline, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Abhilash a

Sharavathi Dental College and Hospital

drabhilashmysore@gmail.com9480327026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026